Ra Medical Systems Inc (AMEX:RMED) saw an upside of 3.49% to $0.65 after adding $0.02 on Monday. The 5-day average trading volume is 138,105 shares of the company’s common stock. It has gained $0.6800 in the past week and touched a new high 2 times within the past 5 days. An average of 157,611 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 315,660.
RMED’s 1-month performance is -13.22% or -$0.1068 on its low of $0.6050 reached on 07/28/23. The company’s shares have touched a 52-week low of $0.61 and high of $11.14, with the stock’s rally to the 52-week high happening on 01/04/23. YTD, RMED has lost -88.96% or -$5.2478 and has reached a new high 2 times. However, the current price is down -94.16% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
RMED stock has a beta of -0.04. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 43.69 while the price-to-book (PB) in the most recent quarter is 0.05.
Ra Medical Systems Inc’s quick ratio for the period ended March 30 was 2.80, with the current ratio over the same period at 2.90. The firm’s gross profit as reported stood at -$0.15 million against revenue of $14000.0.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income grew 91.72% to -$66.4 million, while revenue of -$8.16 million was 87.71% off the previous quarter. Analysts expected RMED to announce -$0.34 per share in earnings in its latest quarter, but it posted -$24.65, representing a -7,150.00% surprise. EBITDA for the quarter stood at more than -$65.04 million. RMED stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 12.65 million, with total debt at $0.14 million. Shareholders hold equity totaling $5.37 million.
Let’s look briefly at Ra Medical Systems Inc (RMED) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 04 August was 34.04% to suggest the stock is trending Neutral, with historical volatility in this time period at 46.48%.
The stock’s 5-day moving average is $0.6386, reflecting a +1.65% or $0.0104 change from its current price. RMED is currently trading -8.24% above its 20-day SMA, -63.72% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -39.99% and SMA200 by-88.22%.
Stochastic %K and %D was 21.33% and 20.72% and the average true range (ATR) pointed at 0.0553. The RSI (14) points at 30.24%, while the 14-day stochastic is at 25.66% with the period’s ATR at 0.0638. The stock’s 9-day MACD Oscillator is pointing at -0.0055 and -0.0197 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Ra Medical Systems Inc (AMEX: RMED), Piper Jaffray downgraded it to a Neutral rating. They previously had an Overweight rating on the stock. Analysts offering their rating for RMED stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate RMED as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is RMED’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $7.00 and a high of $7.00, with their median price target at $7.00. Looking at these predictions, the average price target given by analysts is for Ra Medical Systems Inc (RMED) stock is $7.00.
